| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| NRCNational Research Corporation | 482.6M | 21.30 | 20.48 | -3.72% | 11.76% | 114.31% | 3.97% | 2.06 |
| WORXSCWorx Corp. | 2.91M | 0.18 | -0.24 | -21.43% | -139.71% | -64.87% | 0.01 | |
| DHDefinitive Healthcare Corp. | 251.03M | 2.43 | -0.69 | 0.31% | -77.88% | -48.42% | 18.27% | 0.42 |
| HCATHealth Catalyst, Inc. | 165.51M | 2.34 | -2.03 | 3.6% | -34.05% | -32.42% | 1.10 | |
| ZCMDZhongchao Inc. | 12.21M | 0.47 | -3.95 | -18.37% | -26.94% | -34.62% | 0.00 | |
| EVHEvolent Health, Inc. | 439.71M | 3.94 | -4.86 | 30.09% | -6.24% | -15.22% | 0.71 | |
| FORAForian Inc. | 66.18M | 2.13 | -17.75 | -1.6% | -3.03% | -2.74% | 0.43% | 0.22 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 73.08M | 112.57M | 154.94M | 188.84M | 241.93M | 276.24M | 295.94M | 306.58M |
| Revenue Growth % | - | 0.54% | 0.38% | 0.22% | 0.28% | 0.14% | 0.07% | 0.04% |
| Cost of Goods Sold | 43.64M | 59.85M | 75.34M | 98.08M | 124.35M | 143.05M | 164.1M | 165.81M |
| COGS % of Revenue | 0.6% | 0.53% | 0.49% | 0.52% | 0.51% | 0.52% | 0.55% | 0.54% |
| Gross Profit | 29.44M | 52.72M | 79.6M | 90.77M | 117.57M | 133.19M | 131.83M | 140.78M |
| Gross Margin % | 0.4% | 0.47% | 0.51% | 0.48% | 0.49% | 0.48% | 0.45% | 0.46% |
| Gross Profit Growth % | - | 0.79% | 0.51% | 0.14% | 0.3% | 0.13% | -0.01% | 0.07% |
| Operating Expenses | 74.98M | 112.82M | 134.46M | 186.89M | 261.22M | 273.19M | 258.73M | 210.59M |
| OpEx % of Revenue | 1.03% | 1% | 0.87% | 0.99% | 1.08% | 0.99% | 0.87% | 0.69% |
| Selling, General & Admin | 40.62M | 66.81M | 79M | 114.65M | 160.96M | 149.22M | 143.88M | 111.2M |
| SG&A % of Revenue | 0.56% | 0.59% | 0.51% | 0.61% | 0.67% | 0.54% | 0.49% | 0.36% |
| Research & Development | 28.47M | 38.59M | 46.25M | 53.52M | 62.73M | 75.68M | 72.63M | 57.95M |
| R&D % of Revenue | 0.39% | 0.34% | 0.3% | 0.28% | 0.26% | 0.27% | 0.25% | 0.19% |
| Other Operating Expenses | -4K | -39K | 9.21M | 18.73M | 37.53M | 48.3M | 42.22M | 41.43M |
| Operating Income | -45.54M | -60.09M | -54.87M | -96.13M | -143.65M | -140M | -126.9M | -69.81M |
| Operating Margin % | -0.62% | -0.53% | -0.35% | -0.51% | -0.59% | -0.51% | -0.43% | -0.23% |
| Operating Income Growth % | - | -0.32% | 0.09% | -0.75% | -0.49% | 0.03% | 0.09% | 0.45% |
| EBITDA | -39.65M | -52.68M | -45.65M | -77.4M | -102.54M | -88.48M | -84.67M | -28.38M |
| EBITDA Margin % | -0.54% | -0.47% | -0.29% | -0.41% | -0.42% | -0.32% | -0.29% | -0.09% |
| EBITDA Growth % | - | -0.33% | 0.13% | -0.7% | -0.32% | 0.14% | 0.04% | 0.66% |
| D&A (Non-Cash Add-back) | 5.89M | 7.41M | 9.21M | 18.73M | 41.11M | 51.53M | 42.22M | 41.43M |
| EBIT | -45.54M | -60.09M | -56.53M | -104.64M | -142.79M | -134.44M | -110.5M | -52.08M |
| Net Interest Income | -1.47M | -1.99M | -3.45M | -11.62M | -16.48M | -1.55M | 9.1M | 896K |
| Interest Income | 542K | 602K | 2.81M | 2.09M | 831K | 5.69M | 16.39M | 17.98M |
| Interest Expense | 2.01M | 2.59M | 6.26M | 13.72M | 17.31M | 7.24M | 7.29M | 17.09M |
| Other Income/Expense | -1.47M | -2.02M | -5.09M | -20.09M | -16.46M | -1.68M | 9.11M | 637K |
| Pretax Income | -47.01M | -62.12M | -59.95M | -116.21M | -160.11M | -141.68M | -117.79M | -69.17M |
| Pretax Margin % | -0.64% | -0.55% | -0.39% | -0.62% | -0.66% | -0.51% | -0.4% | -0.23% |
| Income Tax | 26K | -135K | 142K | -1.19M | -6.9M | -4.28M | 356K | 333K |
| Effective Tax Rate % | 1% | 1% | 1% | 0.99% | 0.96% | 0.97% | 1% | 1% |
| Net Income | -47.03M | -61.98M | -60.1M | -115.02M | -153.21M | -137.4M | -118.15M | -69.5M |
| Net Margin % | -0.64% | -0.55% | -0.39% | -0.61% | -0.63% | -0.5% | -0.4% | -0.23% |
| Net Income Growth % | - | -0.32% | 0.03% | -0.91% | -0.33% | 0.1% | 0.14% | 0.41% |
| Net Income (Continuing) | -47.03M | -61.98M | -60.1M | -115.02M | -153.21M | -137.4M | -118.15M | -69.5M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.69 | -2.23 | -3.21 | -2.91 | -3.23 | -2.54 | -2.09 | -1.15 |
| EPS Growth % | - | -0.32% | -0.44% | 0.09% | -0.11% | 0.21% | 0.18% | 0.45% |
| EPS (Basic) | -1.69 | -2.23 | -3.21 | -2.91 | -3.23 | -2.56 | -2.09 | -1.15 |
| Diluted Shares Outstanding | 27.77M | 27.77M | 18.74M | 39.54M | 47.49M | 54.08M | 56.42M | 60.19M |
| Basic Shares Outstanding | 27.77M | 27.77M | 18.74M | 39.54M | 47.49M | 53.72M | 56.42M | 60.19M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 71.39M | 66.86M | 264.24M | 329.8M | 508.39M | 427.8M | 393.4M | 465.65M |
| Cash & Short-Term Investments | 51.46M | 33.19M | 228.28M | 270.87M | 444.98M | 363.49M | 317.73M | 392M |
| Cash Only | 22.98M | 28.43M | 18.03M | 91.95M | 193.23M | 116.31M | 106.28M | 249.65M |
| Short-Term Investments | 28.48M | 4.76M | 210.25M | 178.92M | 251.75M | 247.18M | 211.45M | 142.35M |
| Accounts Receivable | 17.05M | 27.7M | 27.57M | 48.3M | 48.8M | 47.97M | 60.29M | 57.18M |
| Days Sales Outstanding | 85.17 | 89.8 | 64.95 | 93.35 | 73.63 | 63.38 | 74.36 | 68.08 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 762K | 649K | 0 | 0 | 14.61M | 16.34M | 15.38M | 16.47M |
| Total Non-Current Assets | 38.88M | 44.12M | 38.12M | 247.94M | 323.7M | 324.49M | 308.42M | 393.28M |
| Property, Plant & Equipment | 5.38M | 11.02M | 8.08M | 37.59M | 44.45M | 42.59M | 39.64M | 41.45M |
| Fixed Asset Turnover | 13.58x | 10.22x | 19.17x | 5.02x | 5.44x | 6.49x | 7.47x | 7.40x |
| Goodwill | 3.69M | 3.69M | 3.69M | 107.82M | 169.97M | 185.98M | 190.65M | 259.76M |
| Intangible Assets | 29.57M | 28.3M | 25.54M | 98.92M | 104.79M | 92.19M | 73.38M | 86.05M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 243K | 1.1M | 810K | 3.61M | 4.5M | 3.73M | 4.74M | 6.02M |
| Total Assets | 110.27M | 110.97M | 302.36M | 577.74M | 832.1M | 752.29M | 701.81M | 858.93M |
| Asset Turnover | 0.66x | 1.01x | 0.51x | 0.33x | 0.29x | 0.37x | 0.42x | 0.36x |
| Asset Growth % | - | 0.01% | 1.72% | 0.91% | 0.44% | -0.1% | -0.07% | 0.22% |
| Total Current Liabilities | 30.77M | 41.81M | 48.22M | 88.04M | 93.05M | 82.51M | 89.03M | 325.85M |
| Accounts Payable | 833K | 1.81M | 3.62M | 5.33M | 4.69M | 4.42M | 6.64M | 11.43M |
| Days Payables Outstanding | 6.97 | 11.05 | 17.55 | 19.84 | 13.77 | 11.29 | 14.77 | 25.17 |
| Short-Term Debt | 0 | 1.29M | 2.81M | 0 | 0 | 0 | 0 | 231.18M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 16.27M | 5.49M | 4.05M | 24.27M | 10.87M | 7.51M | 11.68M | 11.65M |
| Current Ratio | 2.32x | 1.60x | 5.48x | 3.75x | 5.46x | 5.18x | 4.42x | 1.43x |
| Quick Ratio | 2.32x | 1.60x | 5.48x | 3.75x | 5.46x | 5.18x | 4.42x | 1.43x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 338.98M | 443.94M | 53.5M | 213.6M | 216.95M | 244.77M | 245.86M | 167.87M |
| Long-Term Debt | 9.62M | 18.81M | 48.2M | 168.99M | 180.94M | 226.52M | 228.03M | 151.18M |
| Capital Lease Obligations | 872K | 4.23M | 1.65M | 23.67M | 20.24M | 18.02M | 17.68M | 16.29M |
| Deferred Tax Liabilities | 0 | -4.23M | 1.86M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 328.49M | 413.62M | 0 | 19.06M | 14.83M | 121K | 74K | 154K |
| Total Liabilities | 369.74M | 485.74M | 101.72M | 301.64M | 310M | 327.28M | 334.89M | 493.72M |
| Total Debt | 12.62M | 26.91M | 52.66M | 195.28M | 204.61M | 247.97M | 249.07M | 402.26M |
| Net Debt | -10.35M | -1.52M | 34.63M | 103.33M | 11.38M | 131.66M | 142.79M | 152.62M |
| Debt / Equity | - | - | 0.26x | 0.71x | 0.39x | 0.58x | 0.68x | 1.10x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | -22.69x | -23.23x | -8.76x | -7.01x | -8.30x | -19.34x | -17.41x | -4.09x |
| Total Equity | -259.48M | -374.77M | 200.64M | 276.1M | 522.1M | 425.01M | 366.92M | 365.21M |
| Equity Growth % | - | -0.44% | 1.54% | 0.38% | 0.89% | -0.19% | -0.14% | -0% |
| Book Value per Share | -9.34 | -13.50 | 10.71 | 6.98 | 10.99 | 7.86 | 6.50 | 6.07 |
| Total Shareholders' Equity | -259.48M | -374.77M | 200.64M | 276.1M | 522.1M | 425.01M | 366.92M | 365.21M |
| Common Stock | 5K | 5K | 37K | 43K | 53K | 1.42B | 1.48B | 1.55B |
| Retained Earnings | -259.47M | -374.77M | -610.51M | -725.65M | -878.86M | -999.02M | -1.12B | -1.19B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -12K | -1K | 72K | 61K | -67K | -648K | 33K | -835K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -36.83M | -40.3M | -32.18M | -26.15M | -23.12M | -35.27M | -33.08M | 14.56M |
| Operating CF Margin % | -0.5% | -0.36% | -0.21% | -0.14% | -0.1% | -0.13% | -0.11% | 0.05% |
| Operating CF Growth % | - | -0.09% | 0.2% | 0.19% | 0.12% | -0.53% | 0.06% | 1.44% |
| Net Income | -47.03M | -61.98M | -60.1M | -115.02M | -153.21M | -137.4M | -118.15M | -69.5M |
| Depreciation & Amortization | 5.89M | 7.41M | 9.21M | 18.73M | 37.53M | 48.3M | 42.22M | 41.43M |
| Stock-Based Compensation | 4.24M | 4.2M | 17.84M | 37.96M | 65.14M | 72.1M | 55.76M | 40.13M |
| Deferred Taxes | 14K | -206K | 40K | -1.27M | -7.13M | -4.52M | 8K | 77K |
| Other Non-Cash Items | 225K | 533K | 2.08M | 37.29M | 29.93M | 162K | 750K | 3.08M |
| Working Capital Changes | -166K | 9.75M | -1.27M | -3.83M | 4.62M | -13.91M | -13.67M | -660K |
| Change in Receivables | 4.44M | -3.63M | 127K | -16.45M | 102K | 788K | -13.66M | 4.28M |
| Change in Inventory | -2.56M | 2.46M | -3.65M | 0 | -8.32M | 0 | 0 | 0 |
| Change in Payables | -6.29M | 4.42M | -86K | 8.24M | 5.2M | -4.7M | 4.87M | 5.58M |
| Cash from Investing | 22.41M | 21.4M | -209.6M | -82.56M | -139.68M | -39.02M | 20.29M | -22.9M |
| Capital Expenditures | -3.34M | -2.5M | -4.33M | -10.46M | -18.47M | -2.17M | -1.24M | -1.62M |
| CapEx % of Revenue | 0.05% | 0.02% | 0.03% | 0.06% | 0.08% | 0.01% | 0% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | -831K | -199K | -1.87M | 14K | 22K | -15.22M | -13.04M | -14.77M |
| Cash from Financing | 24.87M | 24.35M | 231.38M | 182.61M | 264.08M | -2.61M | 2.73M | 151.75M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - |
| Other Financing | 15.08M | 23.11M | -689K | -23.37M | 18.9M | 5.78M | 4.54M | -2.15M |
| Net Change in Cash | - | - | - | - | - | - | - | - |
| Free Cash Flow | -40.17M | -42.8M | -36.52M | -36.61M | -41.59M | -52.68M | -47.39M | -1.84M |
| FCF Margin % | -0.55% | -0.38% | -0.24% | -0.19% | -0.17% | -0.19% | -0.16% | -0.01% |
| FCF Growth % | - | -0.07% | 0.15% | -0% | -0.14% | -0.27% | 0.1% | 0.96% |
| FCF per Share | -1.45 | -1.54 | -1.95 | -0.93 | -0.88 | -0.97 | -0.84 | -0.03 |
| FCF Conversion (FCF/Net Income) | 0.78x | 0.65x | 0.54x | 0.23x | 0.15x | 0.26x | 0.28x | -0.21x |
| Interest Paid | 1.03M | 3.94M | 5.56M | 4.98M | 6.36M | 5.75M | 5.75M | 10.12M |
| Taxes Paid | 66K | 31K | 19K | 92K | 138K | 297K | 266K | 10.12M |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -29.95% | -48.25% | -38.39% | -29.02% | -29.84% | -18.99% |
| Return on Invested Capital (ROIC) | - | - | -17.49% | -23.46% | -23.6% | -19.26% | -17.85% | -10.19% |
| Gross Margin | 40.28% | 46.83% | 51.37% | 48.06% | 48.6% | 48.21% | 44.55% | 45.92% |
| Net Margin | -64.36% | -55.06% | -38.79% | -60.91% | -63.33% | -49.74% | -39.92% | -22.67% |
| Debt / Equity | - | - | 0.26x | 0.71x | 0.39x | 0.58x | 0.68x | 1.10x |
| Interest Coverage | -22.69x | -23.23x | -8.76x | -7.01x | -8.30x | -19.34x | -17.41x | -4.09x |
| FCF Conversion | 0.78x | 0.65x | 0.54x | 0.23x | 0.15x | 0.26x | 0.28x | -0.21x |
| Revenue Growth | - | 54.04% | 37.63% | 21.88% | 28.11% | 14.18% | 7.13% | 3.6% |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Recurring Technology | 83.79M | 110.47M | 147.45M | 175.81M | 187.23M | 194.85M |
| Recurring Technology Growth | - | 31.84% | 33.48% | 19.24% | 6.49% | 4.07% |
| One-time Technology | 184K | - | 272K | 480K | 357K | - |
| One-time Technology Growth | - | - | - | 76.47% | -25.62% | - |
Health Catalyst, Inc. (HCAT) reported $316.1M in revenue for fiscal year 2024. This represents a 332% increase from $73.1M in 2017.
Health Catalyst, Inc. (HCAT) grew revenue by 3.6% over the past year. Growth has been modest.
Health Catalyst, Inc. (HCAT) reported a net loss of $107.6M for fiscal year 2024.
Health Catalyst, Inc. (HCAT) has a return on equity (ROE) of -19.0%. Negative ROE indicates the company is unprofitable.
Health Catalyst, Inc. (HCAT) had negative free cash flow of $22.8M in fiscal year 2024, likely due to heavy capital investments.